A hitchhiker's guide to the galaxy - An H. pylori travel guide

Gastroenterology

Volumn 124, Issue 7, 2003, Pages 1983-1985

  Handin, Robert I ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GLYCOPROTEIN IB; VON WILLEBRAND FACTOR;

ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ATROPHIC GASTRITIS; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; DISEASE ASSOCIATION; EDITORIAL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PATHOGENESIS; PATHOGENICITY; PEPTIC ULCER; PERNICIOUS ANEMIA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; STOMACH CARCINOMA; THROMBOCYTE ADHESION;

EID: 0038620371     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00551-1     Document Type: Editorial

References (25)

1. Michel M, et al. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection. Arch Intern Med 2002;162: 1033-1036.
2. Hashino S, et al. Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Int J Hematol 2003;77:188-191.
3. Hino M, et al. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol 2003;82:30-32.
4. Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ, Cox DM. Helicobacter pylori binds von Willebrand Factor and interacts with GPlb to induce platelet aggregation. Gastroenterology 2003;124:1846-1854.
5. Siedlecki CA, et al. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996;88: 2939-2950.
6. Zheng X, et al. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001;276:41059-41063.
7. Zheng X, Majerus EM, Sadler JE. ADAMTS13 and TTP. Curr Opin Hematol 2002;9:389-394.
8. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998;67:395-424.
9. Bienkowska J, Cruz M, Atiemo A, Handin R, Liddington R. The von willebrand factor A3 domain does not contain a metal ion-dependent adhesion site motif. J Biol Chem 1997;272:25162-25167.
10. Cruz MA, Diacovo TG, Emsley J, Liddington R, Handin RI. Mapping the glycoprotein lb-binding site in the von Willebrand factor A1 domain. J Biol Chem 2000;275:19098-19105.
11. Emsley J, Cruz M, Handin R, Liddington R. Crystal structure of the von Willebrand Factor A1 domain and implications for the binding of platelet glycoprotein lb. J Biol Chem 1998;273:10396-10401.
12. Huizinga EG, Martijn van der Plas R, Kroon J, Sixma JJ, Gros P. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding. Structure 1997;5: 1147-1156.
13. Cavasini CE, Tarelho Pereira FJ, Ribeiro WL, Wunderlich G, Ferreira MU. Duffy blood group genotypes among malaria patients in Rondonia, Western Brazilian Amazon. Rev Soc Bras Med Trop 2001;34:591-595.
14. Daniels G, Functional aspects of red cell antigens. Blood Rev 1999;13:14-35.
15. Rios M, Bianco C. The role of blood group antigens in infectious diseases. Semin Hematol 2000;37:177-185.
16. Suh IB, et al. The analysis of Plasmodium vivax Duffy receptor binding domain gene sequence from resurgent Korea isolates. Parasitol Res 2001;87:1007-1010.
17. Albritton LM, Kim JW, Tseng L, Cunningham JM. Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses. J Virol 1993;67: 2091-2706.
18. Closs EI, Rinkes IH, Bader A, Yarmush ML, Cunningham JM. Retroviral infection and expression of cationic amino acid transporters in rodent hepatocytes. J Virol 1993;67:2097-2102.
19. Yang YL, et al. Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmcl. Nat Genet 1999;21:216-219.
20. Bloemenkamp DG, Mali WP, Vissere FL, van der Graaf Y. Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: does study design influence results? Am Heart J 2003;145:409-417.
21. Campbell LA, Kuo CC. Chlamydia pneumoniae and atherosclerosis. Semin Respir Infect 2003;18:48-54.
22. Watt S, Aesch B, Lanotte P, Tranquart F, Quentin R. Viral and bacterial DNA in carotid atherosclerotic lesions, Eur J Clin Microbiol Infect Dis 2003;22:99-105.
23. Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes, J Am Coll Cardiol 2003;41:S37-S42.
24. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107: 363-369.
25. Rifai N, Ridker PM, Inflammatory markers and coronary heart disease. Curr Opin Lipidol 2002;13:383-389.